Unity Bio - UBX Net earnings per share (EPS TTM)
Unity Biotechnology (UBX) bets on senolytics to combat aging, providing the company with significant pricing power. The 12-month net income per share snapshot confirms the current trend, where the -1.63 parameter determines the metric's magnitude. However, the lack of commercial products leaves the company dependent on investment, while the fierce scientific race in biotech creates extreme risks for capital.
Analytical breakdowns and data insights for company Unity Biotechnology Inc. (UBX)
- stock price and consensus target price:
- issuer market value details:
- business book valuation details:
- issuer credit burden and liquidity indicators:
Total Debt to Capital Unity Biotechnology|UBX - Long-Term Liabilities to Capital|Short-Term Debt to Capital Unity Bio|UBX - Company Total Debt|Debts to Book Capitalization Unity Biotechnology, Inc.|UBX - Company Long-Term Loans and Borrowings|Company Short-Term Debt Unity Biotechnology|Quick Liquidity unitybiotechnology.com
- earnings and multiples data:
UBX - Company Net Income|Expected Profit Unity Biotechnology|UBX - Price to Earnings Ratio|Future Price to Earnings Unity Biotechnology, Inc.|UBX - Price to Earnings Adjusted for Growth Rate|EV/EBITDA Multiple Unity Biotechnology, Inc.|UBX - Operating profit before depreciation charges|Net earnings per share for the last 12 months Unity Biotechnology|UBX - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months unitybiotechnology.com|UBX - Earnings growth in current year|Earnings growth forecast for next year Unity Biotechnology
Initial company analysis:Unity Biotechnology (UBX)
Unity Biotechnology focuses on developing innovative therapies against cellular senescence in ophthalmology and neurology. An analysis of the current rolling earnings per share allows for an assessment of the real effectiveness of these developments. This metric is calculated by dividing the total annual net income by the total number of shares. It separates the fundamental trend from market noise. This indicator is critical for valuing an investor's stake in a high-tech bio-business.
Competing companies
Tempus AI - Net earnings per share (EPS TTM)|QGEN: Earnings per share for the last twelve months|IONS: Net earnings per share (EPS TTM)|RGEN - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Avidity|Net earnings per one share for the last twelve months CRISPR CRSP|Net earnings per share for the last 12 months WGS (GeneDx Holdings Corp.)|Earnings per share for the last four quarters RARE|Net earnings per share (EPS TTM) BEAM (Beam Therapeutics)|Sarepta Therapeutics (SRPT) - Net earnings per one share for the last twelve months|Twist Bio - Net earnings per share (EPS TTM)|10x (TXG) - Net earnings per share for the last 12 months|NTLA: Net earnings per share (EPS TTM)|stoketherapeutics.com - Earnings per share for the trailing year|Earnings per share for the last twelve months BioLife Solutions|Earnings per share for the last 12 months WVE (Wave Life Sciences Ltd)|Earnings per share for the last twelve months Maze Tx (MAZE)|SION - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Prime Medicine, Inc. PRME|tayshagtx.com - Earnings per share for the last twelve months|QURE - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months MeiraGTx Holdings|RGNX: Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Solid Corp SLDB|Net earnings per share for the last 12 months OCGN|Net earnings per one share for the last twelve months pacb.com PACB|Net earnings per share for the last 12 months BNTC (Benitec Biopharma)|Net earnings per share (EPS TTM) Design Therapeutics Inc (DSGN)|Net earnings per share (EPS TTM) RCKT (Rocket Pharmaceuticals Inc)|4D Molecular Corp - Earnings per share for the last twelve months|LXEO: Net earnings per share for the last 12 months|KRRO (Korro Bio, Inc.) - Earnings per share for the last 12 months|EDIT: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months SLN|Earnings per share for the last twelve months ProQR|Earnings per share for the last 12 months CDXS (Codexis Bio)|Net earnings per share (EPS TTM) SGMO|Net earnings per share (EPS TTM) nautilus.bio (NAUT)|Metagenomi - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Precision BioSciences Inc. DTIL|GBIO - Earnings per share for the last twelve months|BOLD (Boundless Bio Inc) - Earnings per share for the last 12 months|XCUR: Net earnings per share (EPS TTM)|IMNN - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months PHIO|MBIO (Mustang Bio Corp) - Earnings per share for the last four quarters|Net earnings per share for the last 12 months RNAZ (TransCode Therapeutics)|BNGO - Net earnings per one share for the last twelve months|Applied DNA Sciences - Net earnings per share for the last 12 months|Earnings per share for the trailing year BLUE|ImmunoPrecise - Net earnings per share (EPS TTM)|OMGA: Earnings per share for the last twelve months|OMIC: Net earnings per share (EPS TTM)|RGLS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Syros Pharmaceuticals|Net earnings per one share for the last twelve months telesisbio.com TBIO|Net earnings per share for the last 12 months TCON (TRACON Pharmaceuticals, Inc.)
